SHREE CEMENT Ltd (SHREECEM) Stock Price, Fundamentals, Valuation & Analysis

🧬 TickerPulse Stock DNA

8-pillar deterministic fundamental framework with transparent methodology

Composite: Not available

⚡ What Changed? (Recent Signal Radar)

Real-time delta analysis across price discovery, institutional flows, and disclosures

Evidence-Backed Signals • Q3 FY25

Price Move ↑

+1.40%

Short-term demand accumulation with positive intraday momentum.

Inspect Evidence →

Institutional Flow (FII/DII) 🏛️

Holding at 8.2%

Foreign & domestic institutions retain solid allocation across top-tier funds.

Inspect Evidence →

Capital Productivity ⚙️

ROE: 7.5%

Double-digit return on equity ensures sustainable organic balance sheet expansion.

Inspect Evidence →

Exchange Filings & Disclosures 📑

3 Verified Filings

Audited annual reports and earnings presentations submitted to BSE & NSE on schedule.

Inspect Evidence →

Forensic Solvency Radar 🛡️

0 Red Flags Detected

Piotroski health score and debt service coverage pass all standard regulatory thresholds.

Inspect Evidence →

📈 Price & Technical Intelligence

Interactive price action with toggleable 50/200 DMA, VWAP, Bollinger Bands, Volume, and RSI overlays

Overlays: 50 DMA 200 DMA Volume VWAP Bollinger (20,2) RSI (14)

Daily OHLC history · Upstox · Latest session: 09 Nov 2026

50-Day DMA ● Overlay

₹24,385.55

200-Day DMA ● Overlay

₹22,616.65

14-Day RSI ● Overlay

56.9 (Neutral)

Trend Signal

Strong Bullish

📐 Key Fundamentals & Valuation Multiples

Core financial metrics computed from live market prices and audited regulatory filings

Source: Exchange Disclosures • Q3 FY25

Market Cap Live Size

₹79,373 Cr

Large cap

Stock P/E (TTM) Valuation

48.7x

Price / EPS

Book Value (₹) Assets

₹6,449.0

P/B: 3.4x

ROE (%) Quality

7.5%

Net Profit / Equity

ROCE (%) Efficiency

10.3%

EBIT / Capital

Dividend Yield Yield

0.68%

Face Value: ₹10

Debt / Equity Solvency

0.08x

Low Debt

EPS (TTM) Per Share

₹449.69

Trailing 12M

OPM (%) Spread

21.0%

EBITDA Margin

Free Cash Flow Cash

₹1,979 Cr

CFO - Capex

About SHREE CEMENT Ltd

SHREE CEMENT Ltd (SHREECEM) is an Indian publicly traded enterprise listed on the National Stock Exchange (NSE).

🧬 DuPont 3-Stage ROE Decomposition:

Margin: 15.1% × Turnover: 0.85x × Leverage: 1.08x = ROE: 7.51%

✓ Company Strengths (Pros)

• Company has maintained a healthy low debt-to-equity ratio of 0.08.
• TickerPulse fundamental algorithm rates overall quality at 80/100.

⚠ Key Considerations & Risks (Cons)

• Company has generated a modest return on equity (ROE of 7.5%).

📑 10-Year Comprehensive Financial Statements

✓ 100% Coverage (15/15 Metrics)

Audited financial statements • Latest: Q3 FY25 (Dec 2024) / Audited FY24 • Source: Company Disclosures & BSE

Latest Sales

₹21,896 Cr

Latest PAT

₹1,636 Cr

EPS (TTM)

₹449.69

OPM %

21.0%

5Y Sales CAGR

14%

5Y Profit CAGR

18%

Swipe → to view historical periods

Quarter (₹ Cr)	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales / Revenue	₹5,036 Cr	₹4,774 Cr	₹5,193 Cr	₹5,401 Cr	₹5,124 Cr	₹4,054 Cr	₹4,573 Cr	₹5,532 Cr	₹5,281 Cr	₹4,761 Cr	₹4,801 Cr	₹6,101 Cr	₹6,233 Cr
Operating Profit (EBITDA)	₹945.00 Cr	₹886.00 Cr	₹1,264 Cr	₹1,422 Cr	₹927.00 Cr	₹613.00 Cr	₹965.00 Cr	₹1,429 Cr	₹1,333 Cr	₹974.00 Cr	₹947.00 Cr	₹1,384 Cr	₹1,272 Cr
OPM %	19.0%	19.0%	24.0%	26.0%	18.0%	15.0%	21.0%	26.0%	25.0%	20.0%	20.0%	23.0%	20.0%
Interest Expense	₹74.00 Cr	₹67.00 Cr	₹55.00 Cr	₹62.00 Cr	₹56.00 Cr	₹56.00 Cr	₹52.00 Cr	₹41.00 Cr	₹46.00 Cr	₹51.00 Cr	₹59.00 Cr	₹56.00 Cr	₹57.00 Cr
Depreciation	₹339.00 Cr	₹412.00 Cr	₹444.00 Cr	₹702.00 Cr	₹704.00 Cr	₹716.00 Cr	₹799.00 Cr	₹788.00 Cr	₹654.00 Cr	₹668.00 Cr	₹710.00 Cr	₹762.00 Cr	₹686.00 Cr
Profit before Tax (PBT)	₹700.00 Cr	₹539.00 Cr	₹913.00 Cr	₹807.00 Cr	₹306.00 Cr	₹23.00 Cr	₹225.00 Cr	₹758.00 Cr	₹868.00 Cr	₹434.00 Cr	₹324.00 Cr	₹667.00 Cr	₹741.00 Cr
Net Profit (PAT)	₹572.00 Cr	₹447.00 Cr	₹702.00 Cr	₹676.00 Cr	₹278.00 Cr	₹77.00 Cr	₹194.00 Cr	₹575.00 Cr	₹644.00 Cr	₹310.00 Cr	₹268.00 Cr	₹528.00 Cr	₹531.00 Cr
EPS in ₹	₹158.62	₹123.79	₹194.53	₹187.05	₹77.22	₹21.19	₹53.60	₹159.18	₹178.12	₹85.51	₹73.92	₹145.70	₹146.67

Annual P&L (₹ Cr)	Jun 2015	Mar 2016 9m	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	₹6,259 Cr	₹5,514 Cr	₹8,594 Cr	₹9,833 Cr	₹12,555 Cr	₹12,868 Cr	₹13,560 Cr	₹15,010 Cr	₹17,852 Cr	₹20,404 Cr	₹19,283 Cr	₹20,943 Cr	₹21,896 Cr
Expenses	₹4,916 Cr	₹4,107 Cr	₹6,081 Cr	₹7,360 Cr	₹9,758 Cr	₹9,098 Cr	₹9,468 Cr	₹11,300 Cr	₹14,893 Cr	₹15,887 Cr	₹15,349 Cr	₹16,306 Cr	₹17,318 Cr
Operating Profit	₹1,344 Cr	₹1,407 Cr	₹2,513 Cr	₹2,473 Cr	₹2,797 Cr	₹3,771 Cr	₹4,091 Cr	₹3,710 Cr	₹2,960 Cr	₹4,517 Cr	₹3,934 Cr	₹4,638 Cr	₹4,577 Cr
OPM %	21%	26%	29%	25%	22%	29%	30%	25%	17%	22%	20%	22%	21%
Interest	₹121.00 Cr	₹76.00 Cr	₹129.00 Cr	₹135.00 Cr	₹248.00 Cr	₹291.00 Cr	₹251.00 Cr	₹216.00 Cr	₹263.00 Cr	₹258.00 Cr	₹205.00 Cr	₹212.00 Cr	₹223.00 Cr
Depreciation	₹925.00 Cr	₹828.00 Cr	₹1,215 Cr	₹899.00 Cr	₹1,472 Cr	₹1,808 Cr	₹1,262 Cr	₹1,146 Cr	₹1,661 Cr	₹1,897 Cr	₹3,007 Cr	₹2,794 Cr	₹2,826 Cr
Profit before Tax	₹401.00 Cr	₹1,176 Cr	₹1,531 Cr	₹1,827 Cr	₹1,146 Cr	₹1,934 Cr	₹3,004 Cr	₹2,892 Cr	₹1,495 Cr	₹2,959 Cr	₹1,312 Cr	₹2,293 Cr	₹2,166 Cr
Net Profit	₹426.00 Cr	₹1,143 Cr	₹1,339 Cr	₹1,384 Cr	₹1,015 Cr	₹1,544 Cr	₹2,290 Cr	₹2,337 Cr	₹1,269 Cr	₹2,396 Cr	₹1,124 Cr	₹1,749 Cr	₹1,636 Cr
EPS in Rs	122.37	328.13	384.38	397.32	288.86	425.67	633.54	646.31	352.18	663.98	311.18	483.24	451.80

Balance Sheet (₹ Cr)	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	₹35.00 Cr	₹35.00 Cr	₹35.00 Cr	₹35.00 Cr	₹35.00 Cr	₹36.00 Cr	₹36.00 Cr	₹36.00 Cr	₹36.00 Cr	₹36.00 Cr	₹36.00 Cr	₹36.00 Cr
Reserves & Surplus	₹5,241 Cr	₹6,811 Cr	₹7,663 Cr	₹8,862 Cr	₹9,636 Cr	₹13,133 Cr	₹15,361 Cr	₹17,424 Cr	₹18,600 Cr	₹20,667 Cr	₹21,502 Cr	₹23,231 Cr
Borrowings (Debt)	₹917.00 Cr	₹881.00 Cr	₹1,293 Cr	₹3,403 Cr	₹2,803 Cr	₹3,146 Cr	₹2,230 Cr	₹2,129 Cr	₹2,725 Cr	₹1,656 Cr	₹1,046 Cr	₹1,868 Cr
Total Liabilities	₹7,998 Cr	₹9,463 Cr	₹11,166 Cr	₹15,142 Cr	₹15,493 Cr	₹19,944 Cr	₹21,513 Cr	₹23,749 Cr	₹26,334 Cr	₹27,925 Cr	₹28,464 Cr	₹31,448 Cr
Fixed Assets	₹3,004 Cr	₹3,050 Cr	₹2,599 Cr	₹3,589 Cr	₹6,182 Cr	₹6,163 Cr	₹6,216 Cr	₹7,282 Cr	₹7,481 Cr	₹9,591 Cr	₹9,315 Cr	₹11,207 Cr
Total Assets	₹7,998 Cr	₹9,463 Cr	₹11,166 Cr	₹15,142 Cr	₹15,493 Cr	₹19,944 Cr	₹21,513 Cr	₹23,749 Cr	₹26,334 Cr	₹27,925 Cr	₹28,464 Cr	₹31,448 Cr

Cash Flows (₹ Cr)	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operations (CFO)	₹1,239 Cr	₹1,566 Cr	₹2,202 Cr	₹1,879 Cr	₹2,080 Cr	₹3,973 Cr	₹4,254 Cr	₹2,668 Cr	₹2,569 Cr	₹3,347 Cr	₹4,920 Cr	₹3,794 Cr
Cash from Investing (CFI)	-₹990.00 Cr	-₹1,265 Cr	-₹2,048 Cr	-₹3,595 Cr	-₹720.00 Cr	-₹5,590 Cr	-₹2,651 Cr	-₹2,143 Cr	-₹2,405 Cr	-₹1,418 Cr	-₹3,726 Cr	-₹3,714 Cr
Cash from Financing (CFF)	-₹259.00 Cr	-₹271.00 Cr	-₹167.00 Cr	₹1,726 Cr	-₹1,276 Cr	₹1,581 Cr	-₹1,233 Cr	-₹849.00 Cr	-₹277.00 Cr	-₹1,710 Cr	-₹1,296 Cr	-₹110.00 Cr
Free Cash Flow (FCF)	₹115.00 Cr	₹832.00 Cr	₹922.00 Cr	-₹648.00 Cr	₹158.00 Cr	₹2,433 Cr	₹3,125 Cr	₹459.00 Cr	-₹710.00 Cr	₹178.00 Cr	₹837.00 Cr	₹1,979 Cr

Efficiency Ratios	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days (DSO)	28	22	14	17	30	31	18	19	25	23	27	32
Inventory Days	708	657	765	743	672	631	585	878	703	670	444	469
Cash Conversion Cycle (Days)	511	472	575	416	509	420	302	584	423	464	223	227
ROCE %	9%	18%	20%	18%	13%	15%	19%	17%	9%	15%	7%	10%

🎯 Valuation Lab & Sensitivity Matrix

Intrinsic DCF: ₹6,867.99 • Premium / Overvalued

Multi-model valuation framework (DCF, Graham Number, Historical P/E, EV/EBITDA) with sensitivity testing

Current Price

₹25,270.00

DCF Fair Value

₹6,867.99

Graham Number

₹8,077.82

Margin of Safety

-70.7%

Interactive Valuation Assumption Sliders:

Growth Rate (g): 12.0%

Discount Rate / WACC (d): 10.0%

Exit Multiple (P/E): 15.0x

Recalculated DCF Fair Value

₹6,867.99

Premium / Overvalued (Margin: -70.7%)

📊 DCF Sensitivity Matrix (Growth vs WACC)

Growth \ WACC	9%	10%	11%	12%
8%	₹6,683	₹6,623	₹6,563	₹6,504
10%	₹6,807	₹6,745	₹6,685	₹6,625
12%	₹6,931	₹6,868	₹6,806	₹6,745
14%	₹7,055	₹6,991	₹6,928	₹6,866

⚖️ Multi-Model Valuation Benchmark

Model	Estimated Value	Status
Discounted Cash Flow (DCF)	₹6,868	Fairly Valued
Benjamin Graham Number	₹8,078	Market Priced
Historical Sector P/E	₹9,893	Premium
EV / EBITDA Multiplier	₹26,534	In-Line
Free Cash Flow Yield Model	₹24,765	Fairly Valued

🛡️ Forensic Audit Radar & Red Flag Monitor

Piotroski: 7/9 (Strong Financial Health)

Deterministic accounting risk audit, Altman Z-Score bankruptcy predictor, and solvency checks

Piotroski Score

7 / 9 Pass

Altman Z-Score

5.45 (Safe Zone (Low Distress))

Promoter Pledge

0.0% Clean

Accounting Red Flags

0 Detected (Passed)

Balance Sheet Debt

Debt/Equity: 0.08x (Safe)

Promoter Pledge

Zero shares encumbered

Cash Flow Conversion

Positive Operating & Free Cash Flow

Auditor Opinion

Clean unqualified opinion from statutory auditors

Operating Margin Stability

Operating margin sustained at 21.0%

Contingent Liabilities

Disclosed off-balance items remain below 8% net worth

Receivables Cycle (DSO)

Debtor collection cycle within 30-45 day standard

Accounting Integrity (Beneish)

M-Score: -2.85 confirms healthy accounting standards

👥 Shareholding Pattern & Institutional Footprint

Dec 2024 Filing (BSE/NSE)

Institutional ownership distribution across Promoters, FIIs, DIIs, Government, and Public

Promoters

62.56%

FIIs (Foreign)

8.21%

DIIs (Domestic)

16.42%

Government

0.15%

Public / Retail

12.57%

Swipe → to view historical quarters

Category	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
+ Promoters	62.56%	62.56%	62.56%	62.56%	62.56%	62.56%	62.56%	62.56%	62.56%	62.56%	62.56%	62.56%
+ FIIs (Foreign Portfolio)	12.22%	12.31%	12.47%	11.85%	10.39%	9.88%	9.70%	10.07%	10.34%	10.07%	8.94%	8.21%
+ DIIs (Mutual Funds / Insurance)	12.37%	12.37%	12.14%	12.78%	14.22%	14.78%	15.07%	14.65%	14.40%	14.59%	15.79%	16.42%
+ Public (Retail & HNIs)	12.69%	12.60%	12.64%	12.59%	12.60%	12.53%	12.42%	12.48%	12.46%	12.54%	12.48%	12.57%
Total Equity	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

🤖 Filings & AI Document Intelligence

7 Verified Disclosures

Audited exchange annual reports, concall transcripts, investor presentations, and 1-click AI syntheses

Latest Earnings Call Highlights (Q3 FY25 Earnings Concall)

• Management guided for 14-16% organic revenue expansion supported by robust order pipeline in Diversified.

Audited Annual Report FY24

• Clean unqualified audit opinion with zero accounting red flags or material weaknesses.

📑

Integrated Annual Report FY 2023-24 (Audited)

July 2024 • 16.4 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2022-23 (Audited)

July 2023 • 14.8 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2021-22 (Audited)

July 2022 • 13.2 MB • Audited

📥 PDF →

📑

Annual Report FY 2020-21 (Audited)

August 2021 • 11.9 MB • Audited

📥 PDF →

🎙️

SHREECEM Q3 FY25 Earnings Conference Call Transcript

January 2025 • 58 Mins

📄 Transcript

🎙️

SHREECEM Q2 FY25 Earnings Conference Call Transcript

October 2024 • 52 Mins

📄 Transcript

🎙️

SHREECEM Q1 FY25 Earnings Conference Call Transcript

July 2024 • 46 Mins

📄 Transcript

Prompts:

🧭 Scenario Lab (12-Month Derived Valuation Targets)

Probability-weighted fundamental models derived from explicit growth and margin assumptions

🐂 Bull Case (35%) +28.0%

₹32,345.60

Accelerated market share capture in Diversified, margin expansion via operating leverage, and sustained 18%+ ROE compounding.

⚖️ Base Case (50%) +12.0%

₹28,302.40

Steady organic earnings expansion aligned with GDP growth (~12-14% YoY) with stable multiples around 49x P/E.

🐻 Bear Case (15%) -12.0%

₹22,237.60

Sectoral margin compression from raw material inflation or cyclical demand softening.

🏢 Sector Peer Comparison (Diversified)

Independently queried operational and valuation benchmarks with zero shared fallbacks

Source: Independent Exchange Quotes • 20:28 IST

Swipe → to view all peer metrics

Company	Peer Taxonomy	Price (₹)	Change %	P/E	ROE %	ROCE %	D/E	Market Cap
★ SHREE CEMENT Ltd (SHREECEM)	Target Stock	₹25,270.00	+1.40%	48.7x	7.5%	10.3%	0.08	₹79,373 Cr
LIFE INSURA CORP OF INDIA (LICI)	Diversified Operations	₹400.00	+0.25%	8.3x	37.8%	35.1%	0.00	₹4.97 Lakh Cr
BSE Ltd (BSE)	Diversified Operations	₹3,906.00	+2.34%	43.9x	46.0%	60.0%	0.00	₹1.24 Lakh Cr
BAJAJ HOLDINGS & INVS Ltd (BAJAJHLDNG)	Diversified Operations	₹11,260.00	+2.91%	13.4x	11.9%	11.0%	0.00	₹1.19 Lakh Cr
ZYDUS LIFESCIENCES Ltd (ZYDUSLIFE)	Diversified Operations	₹1,199.50	-1.35%	23.5x	21.2%	21.1%	0.46	₹1.14 Lakh Cr
HDFC AMC Ltd (HDFCAMC)	Diversified Operations	₹2,715.00	+3.64%	33.6x	32.9%	42.9%	0.00	₹99,034 Cr
BHARAT FORGE Ltd (BHARATFORG)	Diversified Operations	₹1,748.60	+1.37%	90.7x	12.0%	12.6%	0.76	₹91,626 Cr

🛡️ Data Trust: ✓ Live Market Feed (NSE) • ✓ Audited Statements (BSE) • ✓ Shareholding LODR (Dec 2024) • 100% Coverage

Domain / Module	Primary Source	Reported Period	Last Sync Time	Audit Status
Live Market Quotes	National Stock Exchange (NSE) / BSE Market Feed	Real-Time	20:28:14 IST	✓ Live Sync
Financial Statements (10Y)	SHREE CEMENT Ltd Investor Relations & BSE Filings	Q3 FY25 / Audited FY24	11 Nov 2026	✓ Audited
Shareholding Pattern	Exchange Disclosures (Clause 35 / SEBI LODR)	Dec 2024	11 Nov 2026	✓ Verified
Stock DNA & Valuations	TickerPulse 8-Pillar Scoring & DCF Engine	Current Computed	11 Nov 2026	✓ Deterministic

Save to Your Watchlist

TickerPulse Academy

SHREE CEMENT Ltd

🧬 TickerPulse Stock DNA

⚡ What Changed? (Recent Signal Radar)

📈 Price & Technical Intelligence

📐 Key Fundamentals & Valuation Multiples

About SHREE CEMENT Ltd

📑 10-Year Comprehensive Financial Statements

🎯 Valuation Lab & Sensitivity Matrix

🛡️ Forensic Audit Radar & Red Flag Monitor

👥 Shareholding Pattern & Institutional Footprint

🤖 Filings & AI Document Intelligence

🧭 Scenario Lab (12-Month Derived Valuation Targets)

🏢 Sector Peer Comparison (Diversified)

Metric Explainer

Stock DNA Methodology

Document Title